Alpha Teknova, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Alpha Teknova, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 2 of the last 3 years; profit grew in 3 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-3.9×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 57% of Healthcare companies in United States.
Cash Locked Ratio
$25For every $100 of sales, $25 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $34 tied up three years earlier.
More money tied up than 55% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 3/3Sales grew in 2 of the last 3 years; profit grew in 3 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by -2% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
-2% / -32%In 3 years sales changed by -2% while total assets changed by -32%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-4.6×Operating cash was negative last year, while some debt falls due within a year.
Higher than 60% of Healthcare companies in United States.
Cash Cushion Ratio
−2%Debt, after subtracting cash, equals 2% of its market value (net debt).
Lower than 70% of Healthcare companies in United States.
Tangible Assets Ratio
88%Of every $100 the company owns, $88 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 59% of Healthcare companies in United States.
Tangible Net Worth Ratio
83%Of every $100 of net worth, $83 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 64% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Alpha Teknova, Inc. made a loss over the last year. Alpha Teknova, Inc. owes $0.35 for every $1 it owns. Alpha Teknova, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossAlpha Teknova, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
6.33The share price is 6.33 times Alpha Teknova, Inc.'s book value per share, higher than 77% of Healthcare companies in United States.
Market cap
$396 MThe total market value of all of Alpha Teknova, Inc.'s shares at today's price (share price × number of shares), larger than 51% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$63 MWhat Alpha Teknova, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.01Net worth divided by the number of shares. The share price of $6.42 is 6.3 times this, which is the P/B above.
Return on equity (ROE)
-24.2%Alpha Teknova, Inc. lost 24.2% of its shareholders' money over the last year, higher than 64% of Healthcare companies in United States.
Owes vs Owns
0.35×Alpha Teknova, Inc. owes $0.35 for every $1 it owns (low), lower than 56% of Healthcare companies in United States.
Dividend yield
NoneAlpha Teknova, Inc. does not currently pay a dividend.
Revenue growth
+7%Revenue rose 7% in the year to Dec 2025, and shrank 1% a year on average over 3 years.
Profit growth
LossAlpha Teknova, Inc. made a loss in each of the last two years.
Profit margin
-42.6%Alpha Teknova, Inc. lost $43 for every $100 of revenue.
Interest cover
Not coveredAlpha Teknova, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtAlpha Teknova, Inc. had $7 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Alpha Teknova, Inc.: $396 M ÷ $63 M (30 Jun 2026) = 6.3.
What is Alpha Teknova, Inc.'s return on equity?
Alpha Teknova, Inc. lost 24.2% of its shareholders' money over the last year, higher than 64% of Healthcare companies in United States.
How much does Alpha Teknova, Inc. owe compared with what it owns?
Alpha Teknova, Inc. owes $0.35 for every $1 it owns (low), lower than 56% of Healthcare companies in United States.
Does Alpha Teknova, Inc. pay a dividend?
No. Alpha Teknova, Inc. does not currently pay a dividend.
Is Alpha Teknova, Inc.'s revenue growing?
Revenue rose 7% in the year to Dec 2025, and shrank 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.